Tubulin/microtubules as novel clozapine targets

AIM: Clozapine is currently the only effective drug for treatment‐resistant schizophrenia; nonetheless, its pharmacological mechanism remains unclear, and its administration is limited because of severe adverse effects. By comparing the binding proteins of clozapine and its derivative olanzapine, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Hino, Mizuki, Kondo, Takeshi, Kunii, Yasuto, Matsumoto, Junya, Wada, Akira, Niwa, Shin‐ichi, Setou, Mitsutoshi, Yabe, Hirooki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919115/
https://www.ncbi.nlm.nih.gov/pubmed/34964309
http://dx.doi.org/10.1002/npr2.12221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919115/
https://www.ncbi.nlm.nih.gov/pubmed/34964309
http://dx.doi.org/10.1002/npr2.12221

Ejemplares similares